515 related articles for article (PubMed ID: 31989830)
1. Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism.
Smolková K; Mikó E; Kovács T; Leguina-Ruzzi A; Sipos A; Bai P
Antioxid Redox Signal; 2020 Nov; 33(13):966-997. PubMed ID: 31989830
[No Abstract] [Full Text] [Related]
2. NRF2 and the Hallmarks of Cancer.
Rojo de la Vega M; Chapman E; Zhang DD
Cancer Cell; 2018 Jul; 34(1):21-43. PubMed ID: 29731393
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning Identifies Pan-Cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related Genes.
Li N; Zhan X
Oxid Med Cell Longev; 2022; 2022():8450087. PubMed ID: 35242279
[TBL] [Abstract][Full Text] [Related]
4. Identification of Nrf2-responsive microRNA networks as putative mediators of myocardial reductive stress.
Quiles JM; Pepin ME; Sunny S; Shelar SB; Challa AK; Dalley B; Hoidal JR; Pogwizd SM; Wende AR; Rajasekaran NS
Sci Rep; 2021 Jun; 11(1):11977. PubMed ID: 34099738
[TBL] [Abstract][Full Text] [Related]
5. Potential Role of Nrf2, HER2, and ALDH in Cancer Stem Cells: A Narrative Review.
Fakhrioliaei A; Tanhaei S; Pakmehr S; Noori Shakir M; Qasim MT; Hariri M; Nouhi Kararoudi A; Valilo M
J Membr Biol; 2024 Apr; 257(1-2):3-16. PubMed ID: 38356054
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?
Shelton P; Jaiswal AK
FASEB J; 2013 Feb; 27(2):414-23. PubMed ID: 23109674
[TBL] [Abstract][Full Text] [Related]
7. Nrf2: A promising therapeutic target in bone-related diseases.
Che J; Yang X; Jin Z; Xu C
Biomed Pharmacother; 2023 Dec; 168():115748. PubMed ID: 37865995
[TBL] [Abstract][Full Text] [Related]
8. The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19.
Emanuele S; Celesia A; D'Anneo A; Lauricella M; Carlisi D; De Blasio A; Giuliano M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360732
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds.
Nosrati N; Bakovic M; Paliyath G
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946660
[TBL] [Abstract][Full Text] [Related]
10. Identification of transcriptome signature for myocardial reductive stress.
Quiles JM; Narasimhan M; Mosbruger T; Shanmugam G; Crossman D; Rajasekaran NS
Redox Biol; 2017 Oct; 13():568-580. PubMed ID: 28768233
[TBL] [Abstract][Full Text] [Related]
11. Redox toxicology of environmental chemicals causing oxidative stress.
Zheng F; Gonçalves FM; Abiko Y; Li H; Kumagai Y; Aschner M
Redox Biol; 2020 Jul; 34():101475. PubMed ID: 32336668
[TBL] [Abstract][Full Text] [Related]
12. The impact of mitochondria on cancer treatment resistance.
van der Merwe M; van Niekerk G; Fourie C; du Plessis M; Engelbrecht AM
Cell Oncol (Dordr); 2021 Oct; 44(5):983-995. PubMed ID: 34244972
[TBL] [Abstract][Full Text] [Related]
13. Prioritization of therapeutic targets for cancers using integrative multi-omics analysis.
Jin X; Mei Y; Yang P; Huang R; Zhang H; Wu Y; Wang M; He X; Jiang Z; Zhu W; Wang L
Hum Genomics; 2024 Apr; 18(1):42. PubMed ID: 38659038
[TBL] [Abstract][Full Text] [Related]
14. Asparagine restriction enhances CD8
Gnanaprakasam JNR; Kushwaha B; Liu L; Chen X; Kang S; Wang T; Cassel TA; Adams CM; Higashi RM; Scott DA; Xin G; Li Z; Yang J; Lane AN; Fan TW; Zhang J; Wang R
Nat Metab; 2023 Aug; 5(8):1423-1439. PubMed ID: 37550596
[TBL] [Abstract][Full Text] [Related]
15. NRF2 and Diabetes: The Good, the Bad, and the Complex.
Dodson M; Shakya A; Anandhan A; Chen J; Garcia JGN; Zhang DD
Diabetes; 2022 Dec; 71(12):2463-2476. PubMed ID: 36409792
[TBL] [Abstract][Full Text] [Related]
16. Diabetic neuropathy: A NRF2 disease?
Neagu M; Constantin C; Surcel M; Munteanu A; Scheau C; Savulescu-Fiedler I; Caruntu C
J Diabetes; 2023 Dec; ():. PubMed ID: 38158644
[TBL] [Abstract][Full Text] [Related]
17. Nrf2, A Target for Precision Oncology in Cancer Prognosis and Treatment.
Ngo HKC; Le H; Surh YJ
J Cancer Prev; 2023 Dec; 28(4):131-142. PubMed ID: 38205365
[TBL] [Abstract][Full Text] [Related]
18. Exploring structural effects in a new class of NRF2 inhibitors.
Hou Z; Lockwood L; Zhang D; Occhiuto CJ; Mo L; Aldrich KE; Stoub HE; Gallo KA; Liby KT; Odom AL
RSC Med Chem; 2023 Jan; 14(1):74-84. PubMed ID: 36760735
[TBL] [Abstract][Full Text] [Related]
19. NRF2 as a regulator of cell metabolism and inflammation in cancer.
He F; Antonucci L; Karin M
Carcinogenesis; 2020 Jun; 41(4):405-416. PubMed ID: 32347301
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Microbacteria Can Contribute to Ovarian Carcinogenesis by Reducing Iron Concentration in Cysts: A Pilot Study.
Kawahara N; Yamanaka S; Nishikawa K; Matsuoka M; Maehana T; Kawaguchi R; Ozu N; Fujii T; Sugimoto A; Yoshizawa A; Kimura F
Microorganisms; 2024 Mar; 12(3):. PubMed ID: 38543589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
